AI Agents for Site Selection in Pharma and Life Sciences

This reference shows how AI agents pursue site selection goals in pharma and life sciences, detailing loop steps, tool use, and a concrete worked example.

By Suhas Bhairav · Updated

Direct Answer

AI agents for site selection in pharma and life sciences are goal-driven software that pursue regulatory fit, cost efficiency, site readiness, and supply chain resilience. They plan steps, call data tools, check results, and finish with a decision or a hand-off. Key outcomes remain with the human team.

Best for: Clinical operations analysts, real estate planners, and supply chain managers.

What AI Agents Can Do in Site Selection in Pharma and Life Sciences

  • Assess regulatory fit

    Evaluate regulatory constraints across target regions, assemble required filings, verify site licenses, and decide whether the site meets regulatory readiness to advance to due diligence.

  • Estimate economic viability

    Pull site-level financial data, model operating costs, compare incentives, and determine if the site aligns with budget targets and ROI thresholds for approval.

  • Screen feasibility

    Collect zoning data, utility availability, and infrastructure metrics, synthesize constraints, and assess whether the site satisfies practical feasibility before site visits are scheduled.

  • Assess supply chain fit

    Map supplier access, logistics routes, cold-chain needs, and risk exposures to confirm that the location supports required supply continuity.

  • Generate decision options

    Create ranked site options, summarize pros and cons, attach supporting data, and present a go/no-go recommendation for leadership review.

  • Prepare due diligence package

    Assemble reports, data provenance, and audit trails, finalize executive summaries, and ready the file for formal internal or regulatory review.

How the Agent Works

  1. Receive goal

    The agent is given a site selection objective with constraints, datasets to access, and success criteria, such as regulatory readiness.

  2. Plan

    The agent outlines tasks, data sources, and tool calls, scheduling data pulls for regulatory status, financials, zoning.

  3. Call tools

    The agent queries regulatory databases, ERP/financial systems, GIS maps, and third-party feasibility reports to collect verified records.

  4. Check result

    The agent validates results against constraints, reconciles inconsistencies, and reissues missing data requests.

  5. Finish or hand off

    If criteria are satisfied, the agent delivers a formal recommendation; otherwise, it escalates with a go/no-go flag for human review.

Worked Example

Selecting a site with regulatory and cost alignment

Illustrative scenario with sample data.

Scenario

A multinational pharma mid-size company evaluates three regions for a new clinical manufacturing hub, needing regulatory alignment, favorable incentives, and reliable cold-chain access.

Input

goal: select top site; constraints: regulatory readiness and capex cap under 100M; data: regulatory status and licenses for each region, tax incentives, utility capacity (MW), labor rates, transit times to suppliers, and historical permitting timelines; sites: A, B, C. current occupancy, land costs, and zoning classifications.

What the agent does

  1. 1) The agent queries regulatory databases and site licenses to verify current approvals for each region and notes gaps requiring filings, then updates the plan with compliance steps.
  2. 2) It requests utility capacity and labor cost data from internal systems and external reports, computes total operating costs, and ranks sites by cost and readiness.
  3. 3) It pulls GIS data for proximity to suppliers and transit times, analyzes risks, and revises the ranking to reflect logistics resilience and identifies strongest contingencies.
  4. 4) It compiles an executive-ready option sheet listing pros, cons, next actions, and flags remaining obstacles that require human sign-off for leadership validation and approval.

Output

Recommended site: Region B. Summary: Region B shows regulatory readiness, favorable incentives, strong utilities, and closer proximity to key suppliers. Score: 86. Supporting data: regulatory status, capex estimates, tax incentives, labor costs, distance to suppliers, and risk indicators. Next steps: initiate due diligence and schedule leadership review.

Human decision

The project sponsor reviews the option sheet, validates the data sources, confirms capex approval, and signs off to proceed to site visits and detailed regulatory filings, which include defined milestones and risk mitigations.

What You Need

  • Access to regulatory databases, licenses, and compliance records needed for all target regions in a shared data environment.
  • Structured financial and tax data from ERP systems and third-party incentives databases for model inputs.
  • Geospatial and utility data feeds from GIS and utility providers with timing data and outages history.
  • Access controls, audit trails, and logging to support data provenance for review by regulators and internal auditors.

Where People Stay in Charge

  • The agent may not approve filings or grant regulatory clearance without a qualified reviewer’s explicit sign-off and documented rationale from the regulatory affairs head.
  • The agent must not disclose confidential supplier data or pricing details without clearance and controlled access in a secure environment to authorized personnel only.
  • The agent should not make final go/no-go decisions without executive review, documented rationale, and an approved risk posture on file for audit readiness.

FAQ

What kinds of data does an AI agent use for site selection in pharma and life sciences?

The agent uses regulatory status, licenses, incentives, utility capacity, labor costs, supplier networks, and transportation routes to support a defendable decision.

When should a human review be required in the site selection loop?

A human review is required when regulatory gaps exist, financial risk is high, or data conflicts cannot be reconciled.

What outputs does the agent produce for leadership?

The agent outputs an option sheet with site rankings, data provenance, risk notes, and a ready executive summary.

How does the agent handle data security and privacy?

The agent uses role-based access, logs data calls, and maintains audit trails to protect confidential information.